Market Research Logo

Pharmaceuticals in South Korea

Pharmaceuticals in South Korea

Summary

Pharmaceuticals in South Korea industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the South Korea pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The South Korean pharmaceuticals market had total revenues of $19.1bn in 2017, representing a compound annual growth rate (CAGR) of 2.3% between 2013 and 2017.
  • South Korea has been classed as a developed pharmaceuticals market since 2010. As such it suffers classic problems that other developed markets are experiencing which will lead to increased spending.
  • Despite an aging population and being one of the most sophisticated healthcare systems in the world, the value of the pharmaceutical market is only forecast to accelerate slightly throughout the forecast period.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Korea
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Korea
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the South Korea pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the South Korea pharmaceuticals market by value in 2017?
  • What will be the size of the South Korea pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the South Korea pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in South Korea's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
CKD Bio Corporation
Daewoong Pharmaceutical Co Ltd
Hanmi Science Co., Ltd.
Pfizer Inc.
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: South Korea pharmaceuticals market value: $ billion, 2013-17
Table 2: South Korea pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: South Korea pharmaceuticals market share: % share, by value, 2017
Table 4: South Korea pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: CKD Bio Corporation: key facts
Table 6: CKD Bio Corporation: key financials ($)
Table 7: CKD Bio Corporation: key financials (KRW)
Table 8: CKD Bio Corporation: key financial ratios
Table 9: Daewoong Pharmaceutical Co Ltd: key facts
Table 10: Daewoong Pharmaceutical Co Ltd: key financials ($)
Table 11: Daewoong Pharmaceutical Co Ltd: key financials (KRW)
Table 12: Daewoong Pharmaceutical Co Ltd: key financial ratios
Table 13: Hanmi Science Co., Ltd.: key facts
Table 14: Hanmi Science Co., Ltd.: key financials ($)
Table 15: Hanmi Science Co., Ltd.: key financials (KRW)
Table 16: Hanmi Science Co., Ltd.: key financial ratios
Table 17: Pfizer Inc.: key facts
Table 18: Pfizer Inc.: key financials ($)
Table 19: Pfizer Inc.: key financial ratios
Table 20: South Korea size of population (million), 2013-17
Table 21: South Korea gdp (constant 2005 prices, $ billion), 2013-17
Table 22: South Korea gdp (current prices, $ billion), 2013-17
Table 23: South Korea inflation, 2013-17
Table 24: South Korea consumer price index (absolute), 2013-17
Table 25: South Korea exchange rate, 2013-17
List of Figures
Figure 1: South Korea pharmaceuticals market value: $ billion, 2013-17
Figure 2: South Korea pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: South Korea pharmaceuticals market share: % share, by value, 2017
Figure 4: South Korea pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in South Korea, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Korea, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Korea, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Korea, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Korea, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Korea, 2017
Figure 11: CKD Bio Corporation: revenues & profitability
Figure 12: CKD Bio Corporation: assets & liabilities
Figure 13: Daewoong Pharmaceutical Co Ltd: revenues & profitability
Figure 14: Daewoong Pharmaceutical Co Ltd: assets & liabilities
Figure 15: Hanmi Science Co., Ltd.: revenues & profitability
Figure 16: Hanmi Science Co., Ltd.: assets & liabilities
Figure 17: Pfizer Inc.: revenues & profitability
Figure 18: Pfizer Inc.: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report